surging up 26 percent, page-29

the reality with mvh is that it is still going to take some time for deals and revenue to flow:

BUT ....

they have done a lot of groundwork in india and china
they have options for raising cash without dilution
the business plan for recurring revenue is on track
management is now fully focused on shareholders interests
the cochlear sims are top notch and fill a gap in the market
the stock is not anywhere near fully valued
worldwide govt health spends are increasing
talk of diversification that will provide instant cash flow
strong hands now hold/management have not sold one share
biostocks due for some sector rotation
roadshows due to start in coming 3-6 months

etc etc